Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden
Search for other papers by Ola Lindgren in
Google Scholar
PubMed
Search for other papers by Pernilla Asp in
Google Scholar
PubMed
Search for other papers by Anna Sundlöv in
Google Scholar
PubMed
Search for other papers by Jan Tennvall in
Google Scholar
PubMed
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Search for other papers by Peter Åsman in
Google Scholar
PubMed
Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden
Search for other papers by Mikael Lantz in
Google Scholar
PubMed
have been studied in vitro, and it was suggested that irradiated lymphocytes of the thyroid are important in the synthesis of autoantibodies in response to iodine-131 [ 13 ]. The aim of the present study was to prospectively investigate if all patients
Search for other papers by Steen J. Bonnema in
Google Scholar
PubMed
Search for other papers by Elisabeth S. Stovgaard in
Google Scholar
PubMed
Search for other papers by Søren Fast in
Google Scholar
PubMed
Search for other papers by Kasper Broedbaek in
Google Scholar
PubMed
Search for other papers by Jon T. Andersen in
Google Scholar
PubMed
Search for other papers by Allan Weimann in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Pharmacology, Bispebjerg Hospital
Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Henrik E. Poulsen in
Google Scholar
PubMed
Introduction For many years radioactive iodine ( 131 I) has been used for treatment of nontoxic goiter, hyperthyroidism and thyroid cancer. During the last decade recombinant human TSH (rhTSH) - a very potent stimulator of the thyroid 131 I
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Thomas Brix in
Google Scholar
PubMed
Search for other papers by Marianne Vogsen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Jeanette Krogh Petersen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
result of interactions between genetic [ 3 ] and environmental triggers, of which cigarette smoking [ 4 , 5 ] and iodine intake [ 6 ] have received most attention. Patients with GD have an increased burden of other morbidities [ 7 ], including an
Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by Elske T. Massolt in
Google Scholar
PubMed
Search for other papers by Mahdi Salih in
Google Scholar
PubMed
Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by Carolien M. Beukhof in
Google Scholar
PubMed
Search for other papers by Boen L.R. Kam in
Google Scholar
PubMed
Search for other papers by J.W. Burger in
Google Scholar
PubMed
Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by W. Edward Visser in
Google Scholar
PubMed
Search for other papers by Ewout J. Hoorn in
Google Scholar
PubMed
Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
Rotterdam between November 2014 and October 2015. Initial therapy consisted of total thyroidectomy. Patients were eligible for inclusion if they were scheduled for treatment with radioactive iodine (RAI); did not use drugs interfering with TH metabolism or
Search for other papers by Christiaan F Mooij in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Timothy D Cheetham in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Simon H Pearce in
Google Scholar
PubMed
Search for other papers by Juliane Léger in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Introduction Purpose and scope of guideline Hyperthyroidism caused by Graves’ disease (GD) is a relatively rare disease in children. Although treatment options are the same as in adults – antithyroid drugs (ATD), radioactive iodine (RAI
Search for other papers by P. Reed Larsen in
Google Scholar
PubMed
Search for other papers by Ann Marie Zavacki in
Google Scholar
PubMed
Introduction When dietary iodine is sufficient, the major product of the thyroid gland is thyroxine (T4) which is secreted at a rate of 10-fold that of 3,5,3′-triiodothyronine (T3) in humans. Thus, a rate-limiting step in thyroid hormone
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Francisco Sousa Santos in
Google Scholar
PubMed
Search for other papers by Rita Joana Santos in
Google Scholar
PubMed
Faculty of Medical Sciences of Lisbon, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is the most common form of thyroid carcinoma [ 1 ]. Most cases of DTC can be effectively treated with surgery followed by levothyroxine therapy and radioactive iodine (RAI) in selected patients
Center of Genomic Medicine, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed
patients with known or suspected nodular thyroid disease and a US-guided fine-needle aspirate (FNA) is considered the gold standard when evaluating cold (without uptake on a technetium-99m scintigraphy) thyroid nodules [ 1 ]. In a borderline iodine
Search for other papers by Mathieu Spaas in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by Annouschka Laenen in
Google Scholar
PubMed
Search for other papers by Jaak Billen in
Google Scholar
PubMed
Search for other papers by Sandra Nuyts in
Google Scholar
PubMed
of DTC usually consists of total thyroidectomy followed by radioactive iodine (RAI) remnant ablation (RRA). Postoperative administration of RAI serves three major goals: the first is to destroy any residual microscopic disease as well as any remaining
Department of Surgery, Ito Hospital, Shibuya-ku, Tokyo, Japan
Search for other papers by Haruhiko Yamazaki in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Aya Saito in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
prognosis of patients with widely invasive FTC is significantly poorer compared to patients with minimally invasive FTC, completion total thyroidectomy with radioactive iodine (RAI) therapy for widely invasive FTC to detect the appearance of distant and